Drug firm Novartis India today reported 6.45% increase in its net profit to Rs 43.18 crore for the quarter ended September 30, 2011 over the same period previous fiscal.
The company had posted a net profit of Rs 40.56 crore for the quarter ended September 30, 2010, Novartis India said in a filing to BSE.
Net sales of the company for the quarter ended September 30, 2011 stood at Rs 206.76 crore as against Rs 184.91 crore for the corresponding period last fiscal, it added.
Net profit of the company for the half year ended September 30, 2011 rose to Rs 80.75 crore from Rs 72.09 crore for the same period last fiscal, Novartis India said.
Pharmaceuticals continued to be the main driver for the company, it added.
Shares of Novartis India were trading at Rs 836 per scrip in late afternoon trade on BSE, up 1.11% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app